2024 ASCO® Annual Meeting Insights Hub
Meeting coverage & Vumedi’s exclusive highlights, all in one place.
Efficacy & Toxicity of 177Lu-PSMA-617 for mCRPC in a Real-World Setting: Results From the U.S. Expanded Access Program and Comparisons With Phase 3 VISION Data
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Vishnu Murthy
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Vishnu Murthy
Chapters
Comments 0
Login to view comments.
Click here to Login
